Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 11, 1998, Pages 1013-1018

  Lin, Dong Xin ^a   Tang, Yong Ming ^b   Peng, Qiong ^a   Lu, Shi Xin ^a   Ambrosone, Christine B ^b   Kadlubar, Fred F ^b  

^a CANCER HOSPITAL   (China)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; NITROSAMINE;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; ESOPHAGUS CANCER; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0031788098     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Li, J. Y., Liu, B. Q , Li, G. Y., Chen, Z. J., and Sun, X. I Atlas of cancer mortality in the People's Republic of China: an aid for cancer control and research. Int. J. Epidemiol., 10. 127-133, 1981.
2. Lu, S. H., Yang, W. X., Guo, L. P., Li, F M , Wang, G. J., Zhang, J. S , and Li, P. Z Determination of N-nitrosamines in gastric juice and urine and a comparison of endogenous formation of N-nitrosoproline and its inhibition in subjects from high-and low-risk areas for esophageal cancer. IARC Sci. Publ., 84: 538-543, 1987
3. Lu, S. H., Chui S X , Yang, W X., Hu, X. N., Guo, L. P., and Li, F. M. Relevance of N-nitrosamines to esophageal cancer in China. IARC Sci. Publ., 105. 11-17, 1991.
4. Cheng, K K., Day, N. E., Duffy, S. W., Lam, T. H., Fok, M., and Wong, J. Pickled vegetables in the aetiology of esophageal cancer in Hong Kong Chinese. Lancet, 339. 1314-1318, 1992.
5. Guengerich, F P. Metabolic activation of carcinogens. Pharmacol. Ther., 54: 17-61, 1992.
6. Guengerich, F. P., and Shimada, T Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol , 4: 391-407, 1991.
7. Chasseaud, L. F. The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents Adv Cancer Res., 29: 175-274, 1979
8. Coles, B., and Ketterer, B The role of glutathione transferases in chemical carcinogenesis. Crit Rev. Biochem Mol. Biol., 25. 47-70, 1990.
9. Guengerich, F. P., Kim, D H., and Iwasaki, M. Role of human cytochrome P-450 HE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol., 4. 168-179, 1991.
10. Yang, C. S., Yoo, J. H., Ishizaki, H., and Hong, J. Cytochrome P450IIE1. roles in nitrosamine metabolism and mechanisms of regulation Drug Metab. Rev., 22: 147-159, 1990.
11. Yang, C S , and Smith, T J Mechanisms of nitrosamine bioactivation and carcinogenesis. Adv. Exp. Med Biol, 387. 385-394, 1996.
12. Hecht, S. S Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol., 11: 559-603, 1998.
13. Ingelman-Sundberg, M., Johansson, I., Yin, H., Terelius, Y., Eliasson, E., Clot, P., and Albano, E Ethanol-inducible cytochrome P4502E1. genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol, 10: 447-452, 1993.
14. Albano, E., Tomasi, A , Person, J. O., Terelius, Y., Goria-Gatti, L , Ingelman-Sundberg, M., and Dianzani, M U. Role of ethanol-inducible cytochrome P-450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem Pharmacol, 41: 1895-1902, 1991.
15. Wheeler, C. W., Wrighton, S A., and Guenthner, T. M. Detection of human lung cytochrome P450s that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA. Biochem. Pharmacol., 44: 183-187, 1992.
16. de Waziers, I., Cugnenc, P. H., Yang, C S., Leroux, J P., and Beaune, P H. Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther., 253: 387-394, 1990.
17. Nakajima, T, Wang, R-S, Nimura, Y., Pin, Y-M, He, M., Vainio, H, Murayama, N., Aoyama, T., and Iida, F. Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas, Carcinogenesis (Lond.), 17 1477-1481, 1996.
18. Guengerich, F P., and Turvy, C G Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J Pharmacol. Exp. Ther., 256: 1189-1194, 1991.
19. Lucas, D., Berthou, F., Dreano, Y., Lozac'h, P , Volant, A., Menez, J. F. Comparison of levels of cytochromes P-450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical liver samples. Alcohol. Clin. Exp. Res., 17 900-905, 1993.
20. Lucas, D., Menez, C., Girre, C , Berthou, F., Bodenez, P., Joannet, I., Hispard, E., Bardou, L-G., and Menez, J-F. Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in health and alcoholic Caucasian subjects. Pharmacogenetics, 5: 298-304, 1995.
21. Hayashi, S., Watanabe, J., and Kawajiri, K. Genetic polymorphism in the 5′-flanking region changes the transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. (Tokyo), 110: 559-565, 1991.
22. Uematsu, F., Kikuchi, H., Motomiya, M., Abe, T., Sagami, I, Omachi, T., Wakui, A , Kanamaru, R., and Watanabe, M Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn. J Cancer Res., 82: 254-256, 1991
23. Hu, Y . Oscarson, M , Johansson, I., Yue, Q-Y., Dahl, M-L , Tabone, M., Arinco, S , Albano, E., and Ingelman-Sundberg, M. Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Mol Pharmacol, 51: 370-376, 1997
24. El-Zein, R A., Zwischenberger, J. B., Abdel-Rahman, S. Z., Sankar, A. B., and Au, W W. Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma. Cancer Lett., 112, 71-78, 1997.
25. Oyama, T., Kawamoto, T., Mizoue, T., Sugio, K., Kodama, Y , Mitsudomi, T., and Yasumoto, K. Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res , 17: 583-587, 1997.
26. Persson, I., Johansson, I., Bergling, H., Dahl, M. L., Seidegard, J., Rylander, R , Rannug, A , Hogberg. J., and Ingelman-Sundberg, M. Genetic polymorphism of cytochrome P4502E1 in a Swedish population: relationship to the incidence of lung cancer. FEBS Lett, 319: 207-211, 1993.
27. Shields, P. G., Ambrosone, C. B , Graham, S., Bowman, E. D., Harrington, A M , Gillenwater, K. A., Marshall, J. R., Vena, J E , Laughlin R., Nemoto, T., and Freudenheim, J. L A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer. Mol. Carcinog , 17: 144-150, 1996.
28. Ladero, J. M., Agundez, J A, Rodriguez-Lescure, A., Diaz-Rubio, M., and Benitez, J. RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma. Gut, 39: 330-333, 1996.
29. Yu, M-W , Gladek-Yarborough, A., Chiamprasert, S., Santella, R. M., Liaw, Y-F., and Chen, C-J. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109: 1266-1273, 1995.
30. London, S. J , Daly, A K , Cooper, J., Carpenter, C. L , Navidi, W. C , Ding, L , and Idle, J. R Lung cancer risk in relation to the CYP2E1 RsaI genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenetics, 6. 151-158. 1996.
31. Kato, S., Shields, P. G, Caporaso, N. E., Sugimura, H., Trivers, G. E., Tucker, M. A , Trump, B. F., Weston, A., and Harris, C. C. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer Cancer Epidemiol. Biomark. Prev., 3: 515-518, 1994.
32. Anwar, W. A., Abdel-Rahman, S. Z., El-Zein, R. A., Mostafa, H. M., and Au, W W. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis (Lond.), 17: 1923-1929, 1996.
33. Kato, S., Shields, P G, Caporaso, N. E , Hoover, R. N., Trump, B. F., Sugimura, H., Weston, A , and Harris, C C Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res., 52: 6712-6715, 1992
34. Hirvonen, A., Husgafvel-Pursiainen, K , Anttila, S., Karjalainen, A., and Vainio, H. The human CYP2E1 gene and lung cancer. Dral and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis (Lond.), 14 85-88, 1993.
35. Lucas, D , Menez, C., Floch, F., Gourlaouen, Y., Sparfel, O., Joannet, I., Bodenez, P., Jezequel, J., Gouerou, H., Berthou, F, Bardou, L-G , and Menez, J-F, Cytochromes P4502E1 and 4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic Caucasians Alcohol Clin. Exp. Res., 20 1033-1037, 1996.
36. Morita, S., Yano, M., Shiozaki, H., Tsujinaka, T , Ebisui, C., Morimoto, T., Kishibuti, M , Fujita, J , Ogawa, A., Taniguchi, M , Inoue, M , Tamura, S., Yamazaki, K , Kikkawa, N., Mizunoya, S., and Monden, M CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous cell carcinoma of the esophagus. Int. J Cancer, 71: 192-195, 1997.
37. Jahnke, V , Matthias, C., Fryer, A , and Strange, R. Glutathione S-transferase and cytochrome P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. Am. J. Surg , 172: 671-673, 1996.
38. Kato, S., Onda, M , Matsukura, N., Tokunaga, A., Matsuda, N , Yamashita, K., and Shields, P G Genetic polymorphisms of the cancer-related gene and Helicobacter pylori infection in Japanese gastric cancer patients: an age and gender matched case-control study Cancer (Phila.), 77: 1654-1661, 1996
39. Sugimura, H., Hamada, G. S , Suzuki, I, Iwase, T., Kiyokawa, E., Kino, I., and Tsugane, S. CYP1A1 and CYP2E1 polymorphism and lung cancer: a case-control study in Rio de Janeiro, Brazil, Pharmacogenetics, 5 (Suppl) S145-S148, 1995.
40. Watanabe, J., Yang, J. P , Eguchi, H., Hayashi, S., Imai, K , Nakachi, K , and Kawajiri, K. An RsaI polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population Jpn. J Cancer Res , 86, 245-248, 1995.
41. Hung, H-C., Chuang, J., Chien, Y-C., Chern, H-D., Chiang, C-P., Hildesheim, A., and Chen, C-J, Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1. environmental factors and risk of oral cancer Cancer Epidemiol. Biomark. Prev., 6: 901-905, 1997.
42. Hildesheim, A., Chen, C-J., Caporaso, N. E., Cheng, Y-J., Hoover, R. N., Hsu, M-M , Levine, P-H., Chen, I-H , Chen, J-Y., Yang, C-S , Daly, A K , and Idle, J Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma. results from a case-control study conducted in Taiwan Cancer Epidemiol. Biomark. Prev., 4: 607-610, 1995
43. Hayes, J D , and Pulford, D. J. The glutathione S-transferase supergene family regulation of GST and the contribution of the enzyme to cancer chemoprotectton and drug resistance. Crit. Rev Biochem Mol. Biol., 30 445-600, 1995.
44. Seidegard, J., Pero, R. W., Miller, D. J., and Beattie, E J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis (Lond.), 7: 751-753, 1986
45. Pemble, S., Schroeder, K R , Spenser, S. R., Meyer, D. J , Hallier, E , Bolt, H. M., Ketterer, B , and Taylor, J B Human glutathione S-transferase theta (GSTT1). cDNA cloning and the characterization of a genetic polymorphism. Biochem J , 300: 271-276, 1994.
46. Zhong, S., Wyllie, A. H., Barnes, D , Wolf, C R., and Spurr, N. K Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer Carcinogenesis (Lond.), 14: 1821-1824, 1993
47. Chenevix-Trench, G , Young, J., Coggan, M., and Board, P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis (Lond.), 16: 1655-1657, 1995.
48. Bell, D. A., Taylor, J. A., Paulson, D. F , Robertson, C. N., Mohler, J L., and Lucier, G W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst , 85: 1159-1164, 1993.
49. Rebbeck, T. R. Molecular epidemiology of glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomark. Prev., 6: 733-743, 1997
50. Peters, W. H M., Roelofs, H M. J , Hectors, M P. C , Nagengast, F M., and Jansen, J. B M. J. Glutathione and glutathione S-transferases in Barren's epithelium. Br J Cancer, 67: 1413-1417, 1993.
51. Harries, L W., Stubbins, M. J., Forman, D., Howard, G. C. W., and Wolf, C. R Identification of genetic polymorphisms at the glutathione S-transferase π locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis (Lond), 18: 641-644, 1997.
52. Zimniak, P., Nanduri, B., Pikula, S., Bandorowicz-Pikula, J., Singhal, S., Srivastava, S. K., Awasthi, S., and Awasthi, J. C. Naturally occurring human glutathione S-transferase GSTP1,1 isoforms with isoleucine and valine at position 104 differ in enzymatic properties. Eur J. Biochem., 224: 893-899, 1994.
53. Hu, X., O'Donnel, R., Srivastava, S K , Xia, H., Zimniak, P , Nanduri, B., Bleicher, R. J., Awasthi, S., Awasthi, Y. C., Ji, X., and Singh, S. V. Active site architecture of polymorphic forms of human glutathione transferase P1-1 accounts for their enantioselectivity and disparate activity in the glutathione conjugation of 7β,8α-dihydroxy-9α,10α-oxy-7,8,9,10-tetrahydrobenzo(a) pyrene. Biochem. Biophys. Res Commun, 235. 424-428, 1997
54. Nimura, Y., Yokoyama, S., Fujimori, M., Aoki, T., Adachi, W., Nasu, T , He, M., Ping, Y-M , and Iida, F. Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking. Cancer (Phila.), 80: 852-857, 1997.
55. Blin, N , and Stafford, D W A general method for isolation of high molecular weight DNA from eukaryotes Nucleic Acids Res., 3: 2303-2308, 1976
56. Arand, M., Muhlbauer, R., Hengstler, J., Jager, E., Fuchs, J., Winkler, L., and Oesch. F A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal. Biochem., 236: 184-186, 1995.
57. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research I. The Analysis of Case-Control Studies. IARC Scientific Publ. No 32, pp. 5-338. Lyon, France: IARC, 1980
58. Watanabe, J , Hayashi, S., and Kawajiri, K Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region J Biochem (Tokyo), 116. 321-326, 1994.
59. Carriere, V., Berthou, F., Baird, S., Belloe, C., Beaune, P., and de Waziers, I Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics, 6. 203-211, 1996
60. Kim, R. B , O'Shea, D., and Wilkinson, G R Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin. Pharmacol. Ther. 57: 645-655, 1995.
61. Kim, R. B , Yamazaki, H., Chiba, K , O'Shea, D., Mimura, F., Guengerich, F. P., Ishizaki, T., Shimada, T., and Wilkinson, G R In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J. Pharmacol Exp. Ther., 279: 4-11, 1996
62. Koop, D. R., and Tierney, D. J. Multiple mechanisms in the regulation of ethanol-inducible cytochrome P-450IIE1. Bioessays, 12: 429-435, 1990.
63. Takahashi, T., Lasker, J M., Rosman, A S., and Lieber, C. S. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology, 17: 236-245, 1993.
64. Wu, X., Amos, C. I., Kernp, B. L., Shi, H , Jiang, H., Wan, Y., and Spitz, M. R. Cytochrome P450 2E1 Dral polymorphism in lung cancer in minority populations Cancer Epidemiol. Biomark Prev , 7. 13-18, 1998.
65. Hu, X., Xia, H., Srivastava, S. K., Herzog, R., Awasthi, Y C, Ji, X., Zimniak, P, and Singh, S. V. Activity of four allclic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys. Res Commun., 238: 397-402, 1997
66. Yu, Y., Taylor, P. R , Li, J Y., Dawsey, S. M., Wang, G. Q., Guo, W. D., Wang, W , Liu, B. Q , Blot, W. J., Shen, Q., and Li, B. Retrospective cohort study of risk factors for esophageal cancer in Linxian, People's Republic of China. Cancer Causes Control, 4 195-202, 1993.
67. Li, J. Y , Ershow, A. G , Chen, Z. J., Wacholder, S , Li, G Y., Guo, W., Li, B., and Blot, W J. A case-control study of cancer of the esophagus and gastric cardia in Linxian. Int. J. Cancer, 43: 755-761, 1989